Teplizumab treatment addresses underlying cause of Type 1
Shares of Precigen have increased after the company’s Phase 1b/2a study of its AG019 ActoBiotics, designed to address the underlying cause of Type 1 diabetes.
Shares of Precigen have increased after the company’s Phase 1b/2a study of its AG019 ActoBiotics, designed to address the underlying cause of Type 1 diabetes.
A lower carbohydrate diet is an effective short-term option for adults living with Type 2 diabetes and overweight or obesity, concludes a report by the
An online event is taking place later this month on diabetes awareness. The event will be presented by diabetes ambassador and advocate Tony Kelly, now
Spirit Pharmacy is the UK’s only home delivery pharmacy offering tailored services for people living with diabetes. Their mission is to make accessing advice, education,
NHS Chief Executive Sir Simon Stevens has announced a trial to support the wider roll-out of artificial pancreas technology across England for people with Type
Researchers at King’s College London are looking for older people with Type 2 diabetes or their carers who have recently started insulin treatment to take
A food intelligence company has raised $4m in funding to start shipping its app which scans Abbott’s Freestyle Libre to help people monitor their blood
Oxford-based Owen Mumford has launched Ateria SafeControl, its next generation of safety pen needles. Described as an active safety pen needle for healthcare professionals who
As reported by Zacks Equity Research in June 2021, Medtronic recently secured two back-to-back European regulatory approvals in the diabetes management space, the first for
With calls for the Body Mass Index (BMI) to be scrapped, one woman shares her experience of being refused treatment for an eating disorder because